Bakdash G, Schneider LP, van Capel TM, Kapsenberg ML, Teunissen MB, de Jong EC
It is fast becoming a core therapeutic category, rivaling oncology and diabetes in pipeline depth
It is possible that participants in the group with neither weight loss nor glucose reduction discontinued or only sporadically used the drug, so we focused on those who achieved a reduction in either outcome, as it is more likely that these individuals used the drug as prescribed
Micronutrient supplementation may be beneficial, though ideally guided by laboratory assessment rather than empiric supplementation
What are the Potential Side Effects or Risks Observed in GHK-Cu Research
Systematic characterization of regulatory variants of blood pressure genes